Nintedanib Slows IPF Progression
SAN DIEGO (MedPage Today) -- The kinase inhibitor nintedanib slowed progression of idiopathic pulmonary fibrosis (IPF) but the effect on exacerbations was less certain, two pivotal trials showed.
Source: MedPage Today Pulmonary - Category: Respiratory Medicine Source Type: news
More News: Respiratory Medicine